oltipraz has been researched along with Carcinoma, Hepatocellular in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SG; Shin, SM | 1 |
| Guillouzo, A; Langouet, S; Morel, F; Piton, A; Rauch, C | 1 |
| Egner, PA; Gange, SJ; Groopman, JD; Jacobson, LP; Kensler, TW; Kuang, SY; Muñoz, A; Qian, GS; Wang, JB; Zhang, BC; Zhu, YR | 1 |
| Chu, H; Kensler, TW; Muñoz, A | 1 |
| Glintborg, B; Kensler, TW; Poulsen, HE; Weimann, A | 1 |
| Kensler, TW; Yates, MS | 1 |
| Buiatti, E | 1 |
| Chen, B; Davidson, NE; Egner, PA; Enger, C; Fang, X; Gordon, GB; Gorman, MB; Groopman, JD; Helzlsouer, KJ; Jacobson, LP; Kensler, TW; Kuang, SY; Li, YF; Muñoz, A; Prochaska, HJ; Qian, GS; Wang, JB; Wu, Y; Yu, LY; Zarba, A; Zhang, BC; Zhang, QN; Zhu, YR | 1 |
| Chen, B; Davidson, NE; Egner, PA; Enger, C; Fang, X; Gordon, GB; Gorman, MB; He, X; Helzlsouer, KJ; Jacobson, LP; Kensler, TW; Kuang, SY; Li, YF; Muñoz, A; Otieno, M; Prochaska, HJ; Qian, GS; Wang, JB; Wang, JS; Wu, Y; Yu, LY; Zarba, A; Zhang, BC; Zhang, QN; Zhu, YR | 1 |
| Chen, B; Davidson, NE; De Flora, S; Egner, PA; Enger, CL; Fang, X; Gordon, GB; Gorman, MB; Groopman, JD; He, X; Jacobson, LP; Kensler, TW; Kuang, SY; Li, YF; Muñoz, A; Prochaska, HJ; Qian, GS; Wang, JB; Wang, JS; Wu, Y; Yu, LY; Zarba, A; Zhang, BC; Zhang, QN; Zhu, YR | 1 |
| Groopman, JD; Jackson, PE | 1 |
5 review(s) available for oltipraz and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Strategies for chemoprevention of liver cancer.
Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Chemoprevention; Chlorophyllides; Clinical Trials as Topic; Female; Forecasting; Humans; Liver Neoplasms; Male; Primary Prevention; Prognosis; Pyrazines; Risk Assessment; Thiones; Thiophenes | 2002 |
Keap1 eye on the target: chemoprevention of liver cancer.
Topics: Aflatoxins; Animals; Anticarcinogenic Agents; Antioxidants; Carcinoma, Hepatocellular; Clinical Trials as Topic; Humans; Intracellular Signaling Peptides and Proteins; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; NF-E2-Related Factor 2; Phenols; Pyrazines; Signal Transduction; Sulfoxides; Thiocyanates; Thiones; Thiophenes; Triterpenes | 2007 |
Chemoprevention of primary liver cancer.
Topics: Anticarcinogenic Agents; Cancer Vaccines; Carcinoma, Hepatocellular; Chemoprevention; Humans; Liver Neoplasms; Nutritional Physiological Phenomena; Pyrazines; Thiones; Thiophenes | 1996 |
Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Hepatocellular; China; Disease Models, Animal; Double-Blind Method; Humans; Liver Neoplasms; Placebos; Pyrazines; Rats; Thiones; Thiophenes; Treatment Outcome | 1997 |
Aflatoxin and liver cancer.
Topics: Aflatoxins; Animals; Anticarcinogenic Agents; Carcinoma, Hepatocellular; China; Environmental Exposure; Genes, p53; Humans; Incidence; Liver Neoplasms; Mutation; Pyrazines; Thiones; Thiophenes | 1999 |
5 trial(s) available for oltipraz and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Assessing the effect of interventions in the context of mixture distributions with detection limits.
Topics: Anticarcinogenic Agents; Biomarkers, Tumor; Carcinogens; Carcinoma, Hepatocellular; China; Double-Blind Method; Humans; Likelihood Functions; Liver Neoplasms; Models, Statistical; Placebos; Pyrazines; Sensitivity and Specificity; Thiones; Thiophenes | 2005 |
Oltipraz chemoprevention trial in Qidong, People's Republic of China: unaltered oxidative biomarkers.
Topics: Anticarcinogenic Agents; Biomarkers; Carcinoma, Hepatocellular; China; DNA; Guanine; Humans; Liver Neoplasms; Oxidation-Reduction; Oxidative Stress; Placebos; Pyrazines; Thiones; Thiophenes | 2006 |
Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.
Topics: Adult; Aflatoxins; Aged; Anticarcinogenic Agents; Carcinoma, Hepatocellular; China; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Hepatitis B; Humans; Liver Neoplasms; Male; Middle Aged; Pyrazines; Thiones; Thiophenes | 1997 |
Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
Topics: Adult; Aflatoxins; Aged; Albumins; Anticarcinogenic Agents; Biomarkers; Carcinoma, Hepatocellular; China; Dose-Response Relationship, Drug; Genotype; Glutathione Transferase; Humans; Liver Neoplasms; Middle Aged; Pyrazines; Radioimmunoassay; Risk Assessment; Thiones; Thiophenes | 1998 |
Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Hepatocellular; China; Disease Models, Animal; Double-Blind Method; Humans; Liver Neoplasms; Placebos; Pyrazines; Rats; Thiones; Thiophenes; Treatment Outcome | 1997 |
2 other study(ies) available for oltipraz and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Inhibition of arachidonic acid and iron-induced mitochondrial dysfunction and apoptosis by oltipraz and novel 1,2-dithiole-3-thione congeners.
Topics: Apoptosis; Arachidonic Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Formazans; Humans; In Situ Nick-End Labeling; Iron; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Pyrazines; Reactive Oxygen Species; Tetrazolium Salts; Thiones; Thiophenes; Time Factors | 2009 |
Involvement of pregnane X receptor in the regulation of CYP2B6 gene expression by oltipraz in human hepatocytes.
Topics: Anticarcinogenic Agents; Aryl Hydrocarbon Hydroxylases; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytochrome P-450 CYP2B6; Gene Expression Regulation; Hepatocytes; Humans; Hydroxylation; Liver Neoplasms; Oxidoreductases, N-Demethylating; Pregnane X Receptor; Pyrazines; Receptors, Steroid; RNA, Messenger; Testosterone; Thiones; Thiophenes | 2010 |